Association of Discontinuing Preinjury Beta-Adrenergic Blockade Medications With Mortality in Severe Blunt Traumatic Brian Injury

BACKGROUND: Beta-adrenergic receptor blocker (BB) administration has been shown to improve survival after traumatic brain injury (TBI). However, studies to date that observe a benefit did not distinguish between continuation of preinjury BB versus de novo initiation of BB. OBJECTIVES: To determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tignanelli, Christopher J., Arbabi, Saman, Iskander, Gaby, Kralovich, Kurt, Scott, John, Sangji, Naveen F., Hemmila, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513140/
https://www.ncbi.nlm.nih.gov/pubmed/37746607
http://dx.doi.org/10.1097/AS9.0000000000000324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513140/
https://www.ncbi.nlm.nih.gov/pubmed/37746607
http://dx.doi.org/10.1097/AS9.0000000000000324

Ejemplares similares